GOLDMAN SACHS GROUP INC - ELEVEN BIOTHERAPEUTICS INC ownership

ELEVEN BIOTHERAPEUTICS INC's ticker is EBIO and the CUSIP is 286221106. A total of 29 filers reported holding ELEVEN BIOTHERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ELEVEN BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2017$35,000
+59.1%
15,810
+18.5%
0.00%
Q2 2016$22,000
+69.2%
13,343
-68.1%
0.00%
Q1 2016$13,000
-59.4%
41,826
+295.2%
0.00%
Q4 2015$32,000
-40.7%
10,584
-52.8%
0.00%
Q3 2015$54,000
-47.6%
22,414
-38.5%
0.00%
Q2 2015$103,000
-25.4%
36,468
+135.1%
0.00%
Q1 2015$138,000
-27.4%
15,513
-3.0%
0.00%
Q4 2014$190,000
+1.6%
15,988
-4.9%
0.00%
Q3 2014$187,000
+6.9%
16,819
+55.9%
0.00%
Q1 2014$175,00010,7850.00%
Other shareholders
ELEVEN BIOTHERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Municipal Employees' Retirement System of Michigan 241,640$382,0000.02%
Virtu Financial LLC 38,546$61,0000.00%
ADVANTAGE INVESTMENT MANAGEMENT, LLC 1,000$2,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 65,000$103,0000.00%
FIDUCIARY TRUST CO 20,000$32,0000.00%
CITIGROUP INC 600$1,0000.00%
PANAGORA ASSET MANAGEMENT INC 20,003$32,0000.00%
MORGAN STANLEY 7,006$11,0000.00%
BlackRock Inc. 443,691$701,0000.00%
Bank of New York Mellon Corp 40,358$64,0000.00%
View complete list of ELEVEN BIOTHERAPEUTICS INC shareholders